Antimicrobial Revision in Patients With Persistent Febrile Neutropenia: A Prospective, Randomized Trial
Latest Information Update: 27 Sep 2024
At a glance
- Drugs Meropenem (Primary) ; Micafungin (Primary)
- Indications Febrile neutropenia
- Focus Therapeutic Use
- 19 Sep 2024 Status changed to withdrawn prior to enrolment, according to ClinicalTrials.gov: US National Institutes of Health record.
- 15 May 2024 Planned End Date changed from 1 Jan 2025 to 1 Apr 2025.
- 15 May 2024 Planned primary completion date changed from 1 Jan 2025 to 1 Apr 2025.